myelofibrosis

the leukemia & lymphoma society has been the largest nonprofit funder of blood cancer research since 1949. visit us to learn more about how you can help.

learn about jakafi® (ruxolitinib) – used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, and adults with certain types of myelofibrosis. jakafi is used to treat adults and children 12 years of age and older with acute graft-versus-host disease (gvhd) who have taken corticosteroids and they did not work well enough. jakafi is also used to treat adults and children 12 years of age and older with chronic gvhd who have taken one or two types of treatments and they did not work well enough.